Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions.
Saved in:
| Title: | Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions. |
|---|---|
| Authors: | Nagaraju GP; Division of Hematology and Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; Division of Medical Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA, USA., Nellipudi H; School of Science, McMaster University, Hamilton, ON, Canada., Ganji C; Division of Hematology and Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Kuppala V; Division of Hematology and Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Ganji SP; Division of Hematology and Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Kumari S; Department of Biotechnology, Dr. B.R. Ambedkar University, Srikakulam, AP, India., Farran B; Department of Hematology/Oncology, Henry Ford Health, Detroit, MI, USA., Srilatha M; Department of Biotechnology, Sri Venkateswara University, Tirupati, Andhra Pradesh, India., Guenter R; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., El-Rayes BF; Division of Medical Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA, USA. belrayes@health.ucsd.edu. |
| Source: | Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 May 05; Vol. 11 (1). Date of Electronic Publication: 2026 May 05. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
